openPR Logo
Press release

Wearable Heart Monitoring Devices Market reaching USD 8.16 billion by 2033 | VivaLNK Inc, SmartCardia Inc, VitalConnect, ACS Diagnostics, medisana GmbH, iRhythm Inc

07-21-2025 01:47 PM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Wearable Heart Monitoring Devices Market - DataM Intelligence

Wearable Heart Monitoring Devices Market - DataM Intelligence

The Wearable Heart Monitoring Devices Market was valued at USD 2.58 billion in 2024 and is projected to grow significantly, reaching USD 8.16 billion by 2033, at a CAGR of 13.8% during the forecast period from 2025 to 2033.

The Wearable Heart Monitoring Devices Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the firm delivers in-depth reports that help clients navigate complex market dynamics, drive strategic growth, and seize new opportunities in an ever-evolving global landscape.

Download your exclusive sample report today: (corporate email gets priority access): https://datamintelligence.com/download-sample/wearable-heart-monitoring-devices-market?sg

Wearable Heart Monitoring Devices Market Overview:

Wearable heart monitoring devices have become increasingly popular for tracking heart rate and pulse in both clinical and personal health settings. These devices come in various forms such as wristbands, smartwatches, chest straps, and rings-providing wireless connectivity to smartphones and computers for easy access to health data. Their accuracy can vary depending on the sensor type and the user's physical activity during usage.

The global wearable heart monitoring devices market is witnessing strong growth, driven by the rising prevalence of cardiovascular diseases, growing health consciousness, and increasing adoption of advanced wearable technologies. Integration of AI, IoT, and cloud computing in these devices enables real-time monitoring and data analytics, creating significant opportunities in remote patient management and personalized fitness tracking.

Additionally, the global shift toward preventive healthcare, a rapidly aging population, and increased digital health investments are further contributing to market expansion. North America currently leads the market due to its robust healthcare infrastructure, high adoption of innovative health solutions, and strong consumer awareness. Meanwhile, the Asia-Pacific region is expected to register the fastest growth, supported by rising healthcare expenditure, large population base, and increasing smartphone penetration.

Wearable Heart Monitoring Devices Industry Trends

Technological Innovation Fueling Growth in the Wearable Heart Monitoring Devices Market
The rapid advancement of technology is a key factor driving the growth of the wearable heart monitoring devices market. Modern devices are now equipped with sophisticated features that significantly improve their accuracy, usability, and clinical relevance. Innovations such as the integration of electrocardiogram (ECG) sensors, photoplethysmography (PPG) sensors, and accelerometers have made it possible to continuously track vital health parameters-including heart rate, blood pressure, blood oxygen levels, and physical activity-in real time.

A notable example of this trend occurred in April 2025, when LifeSignals, Inc. introduced a new Holter monitoring solution at Heart Rhythm 2025 in San Diego, developed in collaboration with UltraLinQ Healthcare Solutions. This new system enhances the efficiency of cardiac diagnostics by cutting down report turnaround time and removing the need to physically return the biosensor device. This innovation is designed to streamline cardiac care and provide healthcare professionals with a more efficient and seamless workflow.

These technological advancements not only improve clinical outcomes but also cater to the rising demand for remote monitoring, making wearable heart monitoring devices more accessible and practical for everyday use.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/wearable-heart-monitoring-devices-market?sg

Strategic Key Players Driving the Wearable Heart Monitoring Devices Market Forward: Medtronic, Qardio Inc, VitalConnect, ACS Diagnostics, medisana GmbH, iRhythm Inc., Koninklijke Philips N.V., VivaLNK, Inc., Abbott, SmartCardia Inc.

Research Methodology:

The global Wearable Heart Monitoring Devices Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.

Segment Covered in the Wearable Heart Monitoring Devices Market:

By Product Type (Chest Straps & Patches, Pulse Oximeters, Blood Pressure Monitors, Smartwatches, Others)

By Technology (Electric Pulse Based, Optical Technology Based)

By Application (Sports and Fitness, Medical Monitoring, Remote Patient Monitoring, Others)

By End User (Hospitals, Homecare Settings, Cardiac Centers, Others)

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?sg

Industry Recent Developments:

✅ WearLinq acquires AMI Cardiac Monitoring (May 2024)
WearLinq acquired AMI, an independent diagnostic testing facility, to broaden deployment of its FDA-cleared eWave 6‐lead wearable ECG patch. This boosts in-house clinical services and nationwide patient access across all 50 U.S. states though financial terms were undisclosed.

✅ HeartcoR Solutions enters exclusive trial-use partnership with Wellysis (April 2025)
HeartcoR obtained exclusive rights to deploy Wellysis's FDA-cleared S‐Patch ECG wearable in global cardiac safety trials. The lightweight, waterproof patch supports continuous ECG monitoring up to 14 days on a single charge a key step into clinical trial verticals.

Regional Analysis for Wearable Heart Monitoring Devices Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Most Frequently Asked Questions in the Wearable Heart Monitoring Devices Market Research Industry:

➠ Who leads the Wearable Heart Monitoring Devices industry and what's their competitive positioning regarding capacity, performance, and profitability?

➠ What growth opportunities and market challenges do Wearable Heart Monitoring Devices market vendors face?

➠ Which segments show the highest growth potential and market share distribution?

➠ What factors are driving or limiting Wearable Heart Monitoring Devices market growth?

➠ What are the dominant sales and distribution strategies in the Wearable Heart Monitoring Devices industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Wearable Heart Monitoring Devices Market reaching USD 8.16 billion by 2033 | VivaLNK Inc, SmartCardia Inc, VitalConnect, ACS Diagnostics, medisana GmbH, iRhythm Inc here

News-ID: 4112160 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

Ultra-Large Volume Wearable Injectors Market Size, Growth Report 2024-2031 | Enable Injections Inc, Medtronic Plc, Amgen Inc, Sensile Medical AG
Ultra-Large Volume Wearable Injectors Market Size, Growth Report 2024-2031 | Ena …
Ultra-Large Volume Wearable Injectors Market is estimated to grow at a CAGR of 6.7% during the forecast period 2024-2031. The Ultra-Large Volume Wearable Injectors Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies,
Wearable Cardioverter Defibrillators Market is projected to reach USD 535.25 million by 2033 | Kestra Medical Technologies, ZOLL Medical Corporation, Abbott, Boston Scientific Corporation, LivaNova PLC
Wearable Cardioverter Defibrillators Market is projected to reach USD 535.25 mil …
The Wearable Cardioverter Defibrillators (WCD) Market was valued at USD 242.69 million in 2024 and is projected to reach USD 535.25 million by 2033, growing at a CAGR of 9.3% during the forecast period 2025-2033. The Wearable Cardioverter Defibrillators Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make
Pet Wearable Market Size, Share, Industry Growth Report 2024-2031 | Datamars, Trovan Ltd, Konectera Inc, Loc8tor Ltd, Garmin Ltd, Allflex USA Inc, Dogtra, Fitbark Inc
Pet Wearable Market Size, Share, Industry Growth Report 2024-2031 | Datamars, Tr …
Pet Wearable Market is estimated to grow at a CAGR of 7.3% during the forecast period 2024-2031. The Pet Wearable Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the firm delivers in-depth
Wearable Injectors Market is expected to reach USD 24.99 billion by 2033 | CeQur Corporation, Sonceboz, Tandem Diabetes Care Inc, Stevanato Group, Ypsomed AG, Amgen Inc, Insulet Corporation
Wearable Injectors Market is expected to reach USD 24.99 billion by 2033 | CeQur …
The Wearable Injectors Market was valued at USD 9.20 billion in 2024 and is projected to grow significantly, reaching approximately USD 24.99 billion by 2033, expanding at a compound annual growth rate (CAGR) of 11.8% during the forecast period from 2025 to 2033. The Wearable Injectors Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable

All 5 Releases


More Releases for Heart

Heart Healthy Foods and Supplements vs Heart Conditions
Heart conditions remain a major health concern worldwide, but the good news is that specific heart healthy foods and supplements can significantly improve cardiovascular health. Scientific research has demonstrated that certain foods, nutrients and supplements support heart function, reduce inflammation, and lower the risk of heart disease. Top Heart Healthy Foods Fatty Fish - Salmon, mackerel, and sardines are rich in omega-3 fatty acids, which help lower blood pressure and reduce inflammation. A
Heart Disease App Market to Witness Huge Growth by 2030 | Cardiio, Blood Pressur …
Global "Heart Disease App Market" Research report is an in-depth study of the market Analysis. Along with the most recent patterns and figures that uncovers a wide examination of the market offer. This report provides exhaustive coverage on geographical segmentation, latest demand scope, growth rate analysis with industry revenue and CAGR status. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study
Longa Heart Health Empowers Individuals with Personalized Heart Disease Preventi …
Experienced Team Creates Tailored Plans to Reduce Risk and Improve Overall Health Erawan, Bangkok - Longa Heart Health [https://longahearthealth.com/en/], a leading provider of non-surgical heart disease treatment, announces its comprehensive approach to heart health with personalized prevention programs. These programs leverage the expertise of a dedicated medical team and advanced diagnostics to create customized plans that address each patient's unique needs. Heart disease remains a leading cause of death globally. By focusing
Centrifugal Heart Pumps Market | Abbott Laboratories, Abiomed, Berlin Heart, Car …
The global centrifugal heart pumps market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the centrifugal heart pumps market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth
Structural Heart Devices Market - Revolutionizing Structural Heart Care with Adv …
Newark, New Castle, USA: The "Structural Heart Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Structural Heart Devices Market: https://www.growthplusreports.com/report/structural-heart-devices-market/8432 This latest report researches the industry structure,
Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue